Search
for
Sort by
Research 601–630 of 1000+
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- 649 Gut microbiota plays a role in the development of alopecia areata
- Alopecia Areata: An Updated Review for 2023
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- RETRACTED: Interleukin‐33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
- Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Transcriptomic crossroads: Decoding genes and pathways that connect alopecia areata with chronic inflammatory skin disorders
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- COVID-19 in Africa: an ovarian victory?
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
- Yangyin Qingre Huoxue Method in Traditional Chinese Medicine Ameliorates Atherosclerosis in ApoE<sup>−/−</sup> Mice Suffering from High-Fat Diet and HSP65 Aggression
- Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Osteopontin Gene Polymorphisms rs1126616 C>T and rs1126772 A>G are Associated with Atopic Dermatitis in Polish Population
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf